Johnson & Johnson is evaluating “strategic options” for its Ortho-Clinical Diagnostics Inc. business, including the possibility of a sale or spin-off.
“Options include a possible divestiture if it is determined that OCD could have greater potential as part of another organization...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?